Ideaya Biosciences Inc
IDYA
Market Cap$2.89B
Close$
$-0.08
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.89 Billion |
|---|---|
| Enterprise Value | $2.37 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.96 |
| Beta | 0.0 |
| Outstanding Shares | 74,764,628 |
| Avg 30 Day Volume | 600,241 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -25.56 |
|---|---|
| PEG | -63.42 |
| Price to Sales | - |
| Price to Book Ratio | 4.99 |
| Enterprise Value to Revenue | 101.14 |
| Enterprise Value to EBIT | -17.59 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata